Search
Selected Filter
Displaying 231–240 of 304 research results
-
ARVO 2016: High-School Sophomore Finds Gene Mutation in Family with Choroideremia
Eye On the Cure Research NewsAditya A. Guru, 16, used whole exome sequencing (WES), an innovative genetic-screening technology, to find the mutation.
-
ARVO 2016: Emerging Drug Targets Toxic Build-Up in Stargardt Disease
Eye On the Cure Research NewsIn August 2015, the biotech company Alkeus launched a multi-center TEASE Phase II clinical trial for the drug ALK-001.
-
ARVO 2016: What Does It Take to Develop a Stem-Cell Therapy for the Retina?
Science EducationThere are innumerable considerations for researchers developing therapies.
-
ARVO 2016: ProgSTAR, FFB-CRI's Stargardt Disease Patient Study, Highlighted
Eye On the Cure Research NewsWhen the study and the reports are completed, the ProgSTAR database will be made available to researchers and companies developing therapies.
-
ARVO 2016: Choroideremia Gene Therapy in Clinical Trial Continues to Perform Well
Eye On the Cure Research NewsFive of six patients in NightStaRx’s choroideremia gene-therapy trial continue to benefit from the treatment.
-
Two New Videos Highlight the Foundation's Vital Role in Retinal Research
Science EducationDr. Shannon Boye and her Foundation-funded research is the subject of not just one but two new Foundation videos.
-
Retinal Researchers May Be Looking for You
Science EducationIf you have a heritable retinal disease, consider registering with My Retina Tracker, the Foundation’s free, secure and confidential registry for people with inherited retinal diseases.
-
Past Sun Exposure Increases AMD Risk
Eye On the Cure Research NewsResearchers from the University of Cologne in Germany and Radboud University in the Netherlands found that increased sunlight exposure during working life significantly increases risk of AMD later in life.
-
A Leap Forward: Spark Therapeutics Seeks FDA Approval for its Vision-Restoring Gene Therapy
Eye On the Cure Research News -
A Surprising Number of Carrier Females are Affected by X-Linked Retinitis Pigmentosa
Science Education40 percent of genetically tested XLRP carriers showed a definitive abnormality in at least one of three visions tests.
